RT Journal Article
T1 Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.
A1 Iacoboni, Gloria
A1 Rejeski, Kai
A1 Villacampa, Guillermo
A1 van Doesum, Jaap A
A1 Chiappella, Annalisa
A1 Bonifazi, Francesca
A1 Lopez-Corral, Lucia
A1 van Aalderen, Michiel
A1 Kwon, Mi
A1 Martínez-Cibrian, Nuria
A1 Bramanti, Stefania
A1 Reguera-Ortega, Juan Luis
A1 Camacho-Arteaga, Lina
A1 Schmidt, Christian
A1 Marín-Niebla, Ana
A1 Kersten, Marie José
A1 Martin Garcia-Sancho, Alejandro
A1 Zinzani, Pier Luigi
A1 Corradini, Paolo
A1 van Meerten, Tom
A1 Subklewe, Marion
A1 Barba, Pere
YR 2022
FD 2022
LK http://hdl.handle.net/10668/20251
UL http://hdl.handle.net/10668/20251
LA en
DS RISalud
RD Apr 18, 2025